webinar
Label-free ultra-high-throughput screening by MALDI Mass Spectrometry
ON-DEMAND | By Bruker
This webinar discusses a new MALDI Time-of-flight (TOF) Mass Spectrometer, designed for ultra-fast label-free screening of biochemical assays...
List view / Grid view
Search results for bruker - 11 results
webinar
2020: Reset your expectation for surface plasmon resonance (SPR)
ON-DEMAND | By Bruker Daltonics
Learn about the latest software tools for Bruker Daltonic’s SPR instrumentation and explore high-throughput screening strategies enabled by their ecosystem.
webinar
Bead Assisted Mass Spectrometry assay platform for targeted proteomics
ON-DEMAND | By Bruker Scientific, LLC
Watch our free on-demand webinar that focuses on the detailed description of the workflow and case studies of BAMS™ assays developed for targets relevant to neurology and virology.
article
Unlocking the potential of natural products in drug discovery
28 March 2024 | By August Allen (Enveda Biosciences), Erica Forsberg (Bruker Life Sciences), Pelle Simpson (Enveda Biosciences)
Natural products play an underappreciated role in drug discovery. Tandem mass spectrometry (MS/MS)-based metabolomics coupled with machine learning is allowing new, highly diverse molecules from natural products to be identified, revealing bioactive compounds and pinpointing promising drug targets. The additional dimension provided by trapped ion mobility (TIMS) enables researchers to…
article
Developments in trapped ion mobility spectrometry
2 October 2023 | By Torsten Müller (Bruker Daltonics)
Torsten Müller from Bruker Daltonics shares how trapped ion mobility spectrometry (TIMS) fundamentally improves immunopeptidomics research and addresses key challenges in this rapidly expanding field.
webinar
timsTOF MALDI PharmaPulse, a trapped ion mobility-enabled mass spec solution for label-free HTS in drug discovery
ON-DEMAND | By Bruker Daltonics
Watch our free on-demand webinar to discover how the new timsTOF MPP product solution, with its dedicated MALDI PharmaPulse 2023 HTS software suite, improves data quality and accelerates high-throughput screening in drug discovery.
article
2023 drug discovery forecast: emerging trends and disruptors revolutionising the industry
12 April 2023 | By Izzy Wood (Drug Target Review)
With advancements in artificial intelligence, precision medicine and gene editing, the field of drug discovery is undergoing a rapid transformation. In this article, Drug Target Review’s Izzy Wood gets the insider knowledge from industry leaders at SLAS 2023, who are experiencing these changes first hand.
article
HTS assays for the identification of small-molecule inhibitors of deubiquitinating enzymes
4 December 2016 | By Elisabeth Weber (HelmholtzZentrum Munchen), Kamyar Hadian (HelmholtzZentrum Munchen), Kenji Schorpp (HelmholtzZentrum Munchen)
The covalent modification of proteins by the attachment of ubiquitin (ubiquitination) is best known for its function to label proteins for proteasomal degradation. However, ubiquitination also plays non-proteasomal roles during signal transduction, DNA repair and protein sorting...
article
Sample preparation automation in label-free compound profiling
31 August 2021 | By Drug Target Review
Following the latest Drug Target Review webinar, supported by Analytik Jena, we put the audience’s questions to the speakers to understand how hardware, software and labware challenges can be successfully overcome.
news
ELRIG UK hosts inaugural Discovery Technologies event
8 May 2018 | By ELRIG
ELRIG (European Laboratory Research & Innovation Group) has announced its first Discovery Technologies meeting, which will take place at Alderley Park, located near Macclesfield in Cheshire.
news
NMR method could uncover details of cancer and neurodegeneration development
1 November 2021 | By Anna Begley (Drug Target Review)
Scientists have used nuclear magnetic resonance (NMR) spectroscopy to investigate the protein p53, which they say could advance cancer studies.